These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 32916398)

  • 21. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.
    Alvarado G; Noor R; Bassett R; Papadopoulos NE; Kim KB; Hwu WJ; Bedikian A; Patel S; Hwu P; Davies MA
    Melanoma Res; 2012 Aug; 22(4):310-5. PubMed ID: 22584956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
    Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
    Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timing of Anticoagulation Resumption and Risk of Ischemic and Hemorrhagic Complications in Patients With ICH and Mechanical Heart Valves.
    Sakusic A; Rabinstein AA; Anisetti B; Mandrekar J; Wijdicks EFM; Freeman WD; Braksick SA
    Neurology; 2024 Aug; 103(4):e209664. PubMed ID: 39102615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical venous thromboembolic prophylaxis is safe and effective for patients with traumatic brain injury when started 24 hours after the absence of hemorrhage progression on head CT.
    Saadeh Y; Gohil K; Bill C; Smith C; Morrison C; Mosher B; Schneider P; Stevens P; Kepros JP
    J Trauma Acute Care Surg; 2012 Aug; 73(2):426-30. PubMed ID: 22846950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes.
    Shaw JR; Douketis J; Le Gal G; Carrier M
    J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study.
    Vestergaard AS; Skjøth F; Lip GY; Larsen TB
    Stroke; 2016 Apr; 47(4):979-85. PubMed ID: 26883499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Length of Thromboprophylaxis in Patients Operated on for a High-Grade Glioma: A Retrospective Study.
    Senders JT; Snijders TJ; van Essen M; van Bentum GM; Seute T; de Vos FY; Smith TR; Robe PA; Broekman MLD
    World Neurosurg; 2018 Jul; 115():e723-e730. PubMed ID: 29715571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study.
    Donato J; Campigotto F; Uhlmann EJ; Coletti E; Neuberg D; Weber GM; Zwicker JI
    Blood; 2015 Jul; 126(4):494-9. PubMed ID: 25987658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
    Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
    BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in anticoagulation for patients with brain tumors.
    Iyengar V; Patell R; Zwicker J
    Best Pract Res Clin Haematol; 2022 Mar; 35(1):101350. PubMed ID: 36030073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures.
    Clark NP; Witt DM; Davies LE; Saito EM; McCool KH; Douketis JD; Metz KR; Delate T
    JAMA Intern Med; 2015 Jul; 175(7):1163-8. PubMed ID: 26010033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients.
    Diaz M; Jo J
    Curr Oncol Rep; 2022 Apr; 24(4):493-500. PubMed ID: 35179708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.
    Lin RJ; Green DL; Shah GL
    Oncologist; 2018 Apr; 23(4):468-473. PubMed ID: 29158366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is anticoagulation for venous thromboembolism safe for Asian elective neurosurgical patients? A single centre study.
    Cheang MY; Yeo TT; Chou N; Lwin S; Ng ZX
    ANZ J Surg; 2019 Jul; 89(7-8):919-924. PubMed ID: 31293073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracranial hemorrhage after head injury among older patients on anticoagulation seen in the emergency department: a population-based cohort study.
    Grewal K; Atzema CL; Austin PC; de Wit K; Sharma S; Mittmann N; Borgundvaag B; McLeod SL
    CMAJ; 2021 Oct; 193(40):E1561-E1567. PubMed ID: 35040805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits.
    Dudley RR; Aziz I; Bonnici A; Saluja RS; Lamoureux J; Kalmovitch B; Gursahaney A; Razek T; Maleki M; Marcoux J
    J Neurotrauma; 2010 Dec; 27(12):2165-72. PubMed ID: 20939698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultra-Early Venous Thromboembolism (VTE) Prophylaxis in Spontaneous Intracerebral Hemorrhage (sICH).
    Kananeh MF; Fonseca-Paricio MJ; Liang JW; Sullivan LT; Sharma K; Shah SO; Vibbert MD
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105476. PubMed ID: 33253987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.